PADMANEE SHARMA to ADP-ribosyl Cyclase 1
This is a "connection" page, showing publications PADMANEE SHARMA has written about ADP-ribosyl Cyclase 1.
Connection Strength
0.920
-
A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer. Cancer Res Commun. 2024 Sep 01; 4(9):2444-2453.
Score: 0.920